Cyclophosphamide potentiates the antitumor effect of immunization with injection of immature dendritic cells into irradiated tumor

Immunol Invest. 2011;40(4):383-99. doi: 10.3109/08820139.2011.552141. Epub 2011 Feb 11.

Abstract

Growth of a tumor on the left flank was suppressed by direct injection of immature DCs (iDCs) into the irradiated tumor on the right thigh (IR/DC). This antitumor immune effect of IR/DC was enhanced by pretreatment with CTX (CTX+IR/DC) and this effect was related with increased number of tumor-specific IFN-γ secreting T cells and decreased ratio of CD4(+)CD25(+)/CD4(+) T cells. The treatment with CTX+IR/DC increased or decreased the levels of IL-2 or IL-10, respectively. These results demonstrated that antitumor effect of IR/DC could be augmented by pretreatment with low-dose CTX, suggesting a new antitumor therapeutic modality of chemoradioimmunotherapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / administration & dosage*
  • Cancer Vaccines / administration & dosage*
  • Cancer Vaccines / immunology
  • Cell Line, Tumor
  • Combined Modality Therapy
  • Cyclophosphamide / administration & dosage*
  • Dendritic Cells / immunology*
  • Female
  • Immunization
  • Interferon-gamma / biosynthesis
  • Mice
  • Mice, Inbred C3H
  • Neoplasms / drug therapy*
  • Neoplasms / immunology
  • Neoplasms / radiotherapy*
  • Radioimmunotherapy
  • T-Lymphocytes / immunology
  • Treatment Outcome
  • Xenograft Model Antitumor Assays

Substances

  • Antineoplastic Agents
  • Cancer Vaccines
  • Interferon-gamma
  • Cyclophosphamide